Fluzone intradermal influenza virus vaccine regulatory update

sanofi's Sanofi Pasteur S.A. vaccines division said FDA accepted for review an sBLA for Fluzone intradermal influenza virus vaccine to prevent seasonal influenza in patients 18-64 years of age. The c...